Streetbeat News

Price Targets

KBH

Keefe, Bruyette & Woods analyst Jade Rahmani maintains a Market Perform rating on KB Home (NYSE:KBH) and raises the price target from $67 to $77.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:40 am

PEB

Compass Point analyst Floris Van Dijkum downgraded Pebblebrook Hotel (NYSE:PEB) from Buy to Neutral and set a $17 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:37 am

WB

Goldman Sachs analyst Timothy Zhao downgrades Weibo (NASDAQ:WB) from Buy to Neutral and sets a $10.6 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:35 am

AAPL

DZ Bank analyst Ingo Wermann downgrades Apple (AAPL) from Buy to Hold and sets a $180 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:34 am

PAR

Needham analyst Mayank Tandon reiterated a Buy rating on PAR Technology (NYSE:PAR) and maintained a $53 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:27 am

CLBT

Needham analyst Mike Cikos has maintained a Buy rating on Cellebrite DI (NASDAQ:CLBT) and increased the price target from $13 to $13.5.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:26 am

OMC

Exane BNP Paribas analyst Lina Ghayor upgrades Omnicom Group (OMC) from Neutral to Outperform and sets a new price target of $115.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:25 am

KRRO

HC Wainwright & Co. analyst Mitchell Kapoor has maintained a Buy rating on Korro Bio (NASDAQ:KRRO) and increased the price target from $100 to $115. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:24 am

NUVB

HC Wainwright & Co. analyst Robert Burns maintains a Buy rating on Nuvation Bio (NUVB) and raises the price target from $5 to $8.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:22 am

GLPG

B of A Securities analyst Jason Gerberry downgraded Galapagos (NASDAQ:GLPG) from Neutral to Underperform and reduced the price target from $41 to $31, indicating a bearish outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:20 am